Global Acute Hepatic Porphyria Drug Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Acute hepatic porphyria drugs are used for the treatment of adult patients with acute hepatic porphyria.
LPI (LP Information)' newest research report, the “Acute Hepatic Porphyria Drug Industry Forecast” looks at past sales and reviews total world Acute Hepatic Porphyria Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Acute Hepatic Porphyria Drug sales for 2023 through 2029. With Acute Hepatic Porphyria Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acute Hepatic Porphyria Drug industry.
This Insight Report provides a comprehensive analysis of the global Acute Hepatic Porphyria Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acute Hepatic Porphyria Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Acute Hepatic Porphyria Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acute Hepatic Porphyria Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acute Hepatic Porphyria Drug.
The global Acute Hepatic Porphyria Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Acute Hepatic Porphyria Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Acute Hepatic Porphyria Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Acute Hepatic Porphyria Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Acute Hepatic Porphyria Drug players cover Alnylam Pharmaceuticals and Recordati Rare Diseases etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Acute Hepatic Porphyria Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Acute hepatic porphyria drugs are used for the treatment of adult patients with acute hepatic porphyria.
LPI (LP Information)' newest research report, the “Acute Hepatic Porphyria Drug Industry Forecast” looks at past sales and reviews total world Acute Hepatic Porphyria Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Acute Hepatic Porphyria Drug sales for 2023 through 2029. With Acute Hepatic Porphyria Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acute Hepatic Porphyria Drug industry.
This Insight Report provides a comprehensive analysis of the global Acute Hepatic Porphyria Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acute Hepatic Porphyria Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Acute Hepatic Porphyria Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acute Hepatic Porphyria Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acute Hepatic Porphyria Drug.
The global Acute Hepatic Porphyria Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Acute Hepatic Porphyria Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Acute Hepatic Porphyria Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Acute Hepatic Porphyria Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Acute Hepatic Porphyria Drug players cover Alnylam Pharmaceuticals and Recordati Rare Diseases etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Acute Hepatic Porphyria Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- 350 Mg
- 313 Mg
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Alnylam Pharmaceuticals
- Recordati Rare Diseases
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acute Hepatic Porphyria Drug Market Size 2018-2029
2.1.2 Acute Hepatic Porphyria Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Acute Hepatic Porphyria Drug Segment by Type
2.2.1 350 Mg
2.2.2 313 Mg
2.3 Acute Hepatic Porphyria Drug Market Size by Type
2.3.1 Acute Hepatic Porphyria Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
2.4 Acute Hepatic Porphyria Drug Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.4.4 Others
2.5 Acute Hepatic Porphyria Drug Market Size by Application
2.5.1 Acute Hepatic Porphyria Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
3 ACUTE HEPATIC PORPHYRIA DRUG MARKET SIZE BY PLAYER
3.1 Acute Hepatic Porphyria Drug Market Size Market Share by Players
3.1.1 Global Acute Hepatic Porphyria Drug Revenue by Players (2018-2023)
3.1.2 Global Acute Hepatic Porphyria Drug Revenue Market Share by Players (2018-2023)
3.2 Global Acute Hepatic Porphyria Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ACUTE HEPATIC PORPHYRIA DRUG BY REGIONS
4.1 Acute Hepatic Porphyria Drug Market Size by Regions (2018-2023)
4.2 Americas Acute Hepatic Porphyria Drug Market Size Growth (2018-2023)
4.3 APAC Acute Hepatic Porphyria Drug Market Size Growth (2018-2023)
4.4 Europe Acute Hepatic Porphyria Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Acute Hepatic Porphyria Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Acute Hepatic Porphyria Drug Market Size by Country (2018-2023)
5.2 Americas Acute Hepatic Porphyria Drug Market Size by Type (2018-2023)
5.3 Americas Acute Hepatic Porphyria Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acute Hepatic Porphyria Drug Market Size by Region (2018-2023)
6.2 APAC Acute Hepatic Porphyria Drug Market Size by Type (2018-2023)
6.3 APAC Acute Hepatic Porphyria Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Acute Hepatic Porphyria Drug by Country (2018-2023)
7.2 Europe Acute Hepatic Porphyria Drug Market Size by Type (2018-2023)
7.3 Europe Acute Hepatic Porphyria Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acute Hepatic Porphyria Drug by Region (2018-2023)
8.2 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ACUTE HEPATIC PORPHYRIA DRUG MARKET FORECAST
10.1 Global Acute Hepatic Porphyria Drug Forecast by Regions (2024-2029)
10.1.1 Global Acute Hepatic Porphyria Drug Forecast by Regions (2024-2029)
10.1.2 Americas Acute Hepatic Porphyria Drug Forecast
10.1.3 APAC Acute Hepatic Porphyria Drug Forecast
10.1.4 Europe Acute Hepatic Porphyria Drug Forecast
10.1.5 Middle East & Africa Acute Hepatic Porphyria Drug Forecast
10.2 Americas Acute Hepatic Porphyria Drug Forecast by Country (2024-2029)
10.2.1 United States Acute Hepatic Porphyria Drug Market Forecast
10.2.2 Canada Acute Hepatic Porphyria Drug Market Forecast
10.2.3 Mexico Acute Hepatic Porphyria Drug Market Forecast
10.2.4 Brazil Acute Hepatic Porphyria Drug Market Forecast
10.3 APAC Acute Hepatic Porphyria Drug Forecast by Region (2024-2029)
10.3.1 China Acute Hepatic Porphyria Drug Market Forecast
10.3.2 Japan Acute Hepatic Porphyria Drug Market Forecast
10.3.3 Korea Acute Hepatic Porphyria Drug Market Forecast
10.3.4 Southeast Asia Acute Hepatic Porphyria Drug Market Forecast
10.3.5 India Acute Hepatic Porphyria Drug Market Forecast
10.3.6 Australia Acute Hepatic Porphyria Drug Market Forecast
10.4 Europe Acute Hepatic Porphyria Drug Forecast by Country (2024-2029)
10.4.1 Germany Acute Hepatic Porphyria Drug Market Forecast
10.4.2 France Acute Hepatic Porphyria Drug Market Forecast
10.4.3 UK Acute Hepatic Porphyria Drug Market Forecast
10.4.4 Italy Acute Hepatic Porphyria Drug Market Forecast
10.4.5 Russia Acute Hepatic Porphyria Drug Market Forecast
10.5 Middle East & Africa Acute Hepatic Porphyria Drug Forecast by Region (2024-2029)
10.5.1 Egypt Acute Hepatic Porphyria Drug Market Forecast
10.5.2 South Africa Acute Hepatic Porphyria Drug Market Forecast
10.5.3 Israel Acute Hepatic Porphyria Drug Market Forecast
10.5.4 Turkey Acute Hepatic Porphyria Drug Market Forecast
10.5.5 GCC Countries Acute Hepatic Porphyria Drug Market Forecast
10.6 Global Acute Hepatic Porphyria Drug Forecast by Type (2024-2029)
10.7 Global Acute Hepatic Porphyria Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Information
11.1.2 Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Product Offered
11.1.3 Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Alnylam Pharmaceuticals Main Business Overview
11.1.5 Alnylam Pharmaceuticals Latest Developments
11.2 Recordati Rare Diseases
11.2.1 Recordati Rare Diseases Company Information
11.2.2 Recordati Rare Diseases Acute Hepatic Porphyria Drug Product Offered
11.2.3 Recordati Rare Diseases Acute Hepatic Porphyria Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Recordati Rare Diseases Main Business Overview
11.2.5 Recordati Rare Diseases Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acute Hepatic Porphyria Drug Market Size 2018-2029
2.1.2 Acute Hepatic Porphyria Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Acute Hepatic Porphyria Drug Segment by Type
2.2.1 350 Mg
2.2.2 313 Mg
2.3 Acute Hepatic Porphyria Drug Market Size by Type
2.3.1 Acute Hepatic Porphyria Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
2.4 Acute Hepatic Porphyria Drug Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.4.4 Others
2.5 Acute Hepatic Porphyria Drug Market Size by Application
2.5.1 Acute Hepatic Porphyria Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
3 ACUTE HEPATIC PORPHYRIA DRUG MARKET SIZE BY PLAYER
3.1 Acute Hepatic Porphyria Drug Market Size Market Share by Players
3.1.1 Global Acute Hepatic Porphyria Drug Revenue by Players (2018-2023)
3.1.2 Global Acute Hepatic Porphyria Drug Revenue Market Share by Players (2018-2023)
3.2 Global Acute Hepatic Porphyria Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ACUTE HEPATIC PORPHYRIA DRUG BY REGIONS
4.1 Acute Hepatic Porphyria Drug Market Size by Regions (2018-2023)
4.2 Americas Acute Hepatic Porphyria Drug Market Size Growth (2018-2023)
4.3 APAC Acute Hepatic Porphyria Drug Market Size Growth (2018-2023)
4.4 Europe Acute Hepatic Porphyria Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Acute Hepatic Porphyria Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Acute Hepatic Porphyria Drug Market Size by Country (2018-2023)
5.2 Americas Acute Hepatic Porphyria Drug Market Size by Type (2018-2023)
5.3 Americas Acute Hepatic Porphyria Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acute Hepatic Porphyria Drug Market Size by Region (2018-2023)
6.2 APAC Acute Hepatic Porphyria Drug Market Size by Type (2018-2023)
6.3 APAC Acute Hepatic Porphyria Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Acute Hepatic Porphyria Drug by Country (2018-2023)
7.2 Europe Acute Hepatic Porphyria Drug Market Size by Type (2018-2023)
7.3 Europe Acute Hepatic Porphyria Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acute Hepatic Porphyria Drug by Region (2018-2023)
8.2 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ACUTE HEPATIC PORPHYRIA DRUG MARKET FORECAST
10.1 Global Acute Hepatic Porphyria Drug Forecast by Regions (2024-2029)
10.1.1 Global Acute Hepatic Porphyria Drug Forecast by Regions (2024-2029)
10.1.2 Americas Acute Hepatic Porphyria Drug Forecast
10.1.3 APAC Acute Hepatic Porphyria Drug Forecast
10.1.4 Europe Acute Hepatic Porphyria Drug Forecast
10.1.5 Middle East & Africa Acute Hepatic Porphyria Drug Forecast
10.2 Americas Acute Hepatic Porphyria Drug Forecast by Country (2024-2029)
10.2.1 United States Acute Hepatic Porphyria Drug Market Forecast
10.2.2 Canada Acute Hepatic Porphyria Drug Market Forecast
10.2.3 Mexico Acute Hepatic Porphyria Drug Market Forecast
10.2.4 Brazil Acute Hepatic Porphyria Drug Market Forecast
10.3 APAC Acute Hepatic Porphyria Drug Forecast by Region (2024-2029)
10.3.1 China Acute Hepatic Porphyria Drug Market Forecast
10.3.2 Japan Acute Hepatic Porphyria Drug Market Forecast
10.3.3 Korea Acute Hepatic Porphyria Drug Market Forecast
10.3.4 Southeast Asia Acute Hepatic Porphyria Drug Market Forecast
10.3.5 India Acute Hepatic Porphyria Drug Market Forecast
10.3.6 Australia Acute Hepatic Porphyria Drug Market Forecast
10.4 Europe Acute Hepatic Porphyria Drug Forecast by Country (2024-2029)
10.4.1 Germany Acute Hepatic Porphyria Drug Market Forecast
10.4.2 France Acute Hepatic Porphyria Drug Market Forecast
10.4.3 UK Acute Hepatic Porphyria Drug Market Forecast
10.4.4 Italy Acute Hepatic Porphyria Drug Market Forecast
10.4.5 Russia Acute Hepatic Porphyria Drug Market Forecast
10.5 Middle East & Africa Acute Hepatic Porphyria Drug Forecast by Region (2024-2029)
10.5.1 Egypt Acute Hepatic Porphyria Drug Market Forecast
10.5.2 South Africa Acute Hepatic Porphyria Drug Market Forecast
10.5.3 Israel Acute Hepatic Porphyria Drug Market Forecast
10.5.4 Turkey Acute Hepatic Porphyria Drug Market Forecast
10.5.5 GCC Countries Acute Hepatic Porphyria Drug Market Forecast
10.6 Global Acute Hepatic Porphyria Drug Forecast by Type (2024-2029)
10.7 Global Acute Hepatic Porphyria Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Information
11.1.2 Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Product Offered
11.1.3 Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Alnylam Pharmaceuticals Main Business Overview
11.1.5 Alnylam Pharmaceuticals Latest Developments
11.2 Recordati Rare Diseases
11.2.1 Recordati Rare Diseases Company Information
11.2.2 Recordati Rare Diseases Acute Hepatic Porphyria Drug Product Offered
11.2.3 Recordati Rare Diseases Acute Hepatic Porphyria Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Recordati Rare Diseases Main Business Overview
11.2.5 Recordati Rare Diseases Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Acute Hepatic Porphyria Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of 350 Mg
Table 3. Major Players of 313 Mg
Table 4. Acute Hepatic Porphyria Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Acute Hepatic Porphyria Drug Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
Table 7. Acute Hepatic Porphyria Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Acute Hepatic Porphyria Drug Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
Table 10. Global Acute Hepatic Porphyria Drug Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Acute Hepatic Porphyria Drug Revenue Market Share by Player (2018-2023)
Table 12. Acute Hepatic Porphyria Drug Key Players Head office and Products Offered
Table 13. Acute Hepatic Porphyria Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Acute Hepatic Porphyria Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Acute Hepatic Porphyria Drug Market Size Market Share by Regions (2018-2023)
Table 18. Global Acute Hepatic Porphyria Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Acute Hepatic Porphyria Drug Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Acute Hepatic Porphyria Drug Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Acute Hepatic Porphyria Drug Market Size Market Share by Country (2018-2023)
Table 22. Americas Acute Hepatic Porphyria Drug Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
Table 24. Americas Acute Hepatic Porphyria Drug Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
Table 26. APAC Acute Hepatic Porphyria Drug Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Acute Hepatic Porphyria Drug Market Size Market Share by Region (2018-2023)
Table 28. APAC Acute Hepatic Porphyria Drug Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
Table 30. APAC Acute Hepatic Porphyria Drug Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
Table 32. Europe Acute Hepatic Porphyria Drug Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Acute Hepatic Porphyria Drug Market Size Market Share by Country (2018-2023)
Table 34. Europe Acute Hepatic Porphyria Drug Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
Table 36. Europe Acute Hepatic Porphyria Drug Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Acute Hepatic Porphyria Drug
Table 45. Key Market Challenges & Risks of Acute Hepatic Porphyria Drug
Table 46. Key Industry Trends of Acute Hepatic Porphyria Drug
Table 47. Global Acute Hepatic Porphyria Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Acute Hepatic Porphyria Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Acute Hepatic Porphyria Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Acute Hepatic Porphyria Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Alnylam Pharmaceuticals Details, Company Type, Acute Hepatic Porphyria Drug Area Served and Its Competitors
Table 52. Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Product Offered
Table 53. Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Alnylam Pharmaceuticals Main Business
Table 55. Alnylam Pharmaceuticals Latest Developments
Table 56. Recordati Rare Diseases Details, Company Type, Acute Hepatic Porphyria Drug Area Served and Its Competitors
Table 57. Recordati Rare Diseases Acute Hepatic Porphyria Drug Product Offered
Table 58. Recordati Rare Diseases Main Business
Table 59. Recordati Rare Diseases Acute Hepatic Porphyria Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Recordati Rare Diseases Latest Developments
Table 1. Acute Hepatic Porphyria Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of 350 Mg
Table 3. Major Players of 313 Mg
Table 4. Acute Hepatic Porphyria Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Acute Hepatic Porphyria Drug Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
Table 7. Acute Hepatic Porphyria Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Acute Hepatic Porphyria Drug Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
Table 10. Global Acute Hepatic Porphyria Drug Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Acute Hepatic Porphyria Drug Revenue Market Share by Player (2018-2023)
Table 12. Acute Hepatic Porphyria Drug Key Players Head office and Products Offered
Table 13. Acute Hepatic Porphyria Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Acute Hepatic Porphyria Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Acute Hepatic Porphyria Drug Market Size Market Share by Regions (2018-2023)
Table 18. Global Acute Hepatic Porphyria Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Acute Hepatic Porphyria Drug Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Acute Hepatic Porphyria Drug Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Acute Hepatic Porphyria Drug Market Size Market Share by Country (2018-2023)
Table 22. Americas Acute Hepatic Porphyria Drug Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
Table 24. Americas Acute Hepatic Porphyria Drug Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
Table 26. APAC Acute Hepatic Porphyria Drug Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Acute Hepatic Porphyria Drug Market Size Market Share by Region (2018-2023)
Table 28. APAC Acute Hepatic Porphyria Drug Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
Table 30. APAC Acute Hepatic Porphyria Drug Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
Table 32. Europe Acute Hepatic Porphyria Drug Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Acute Hepatic Porphyria Drug Market Size Market Share by Country (2018-2023)
Table 34. Europe Acute Hepatic Porphyria Drug Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
Table 36. Europe Acute Hepatic Porphyria Drug Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Acute Hepatic Porphyria Drug
Table 45. Key Market Challenges & Risks of Acute Hepatic Porphyria Drug
Table 46. Key Industry Trends of Acute Hepatic Porphyria Drug
Table 47. Global Acute Hepatic Porphyria Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Acute Hepatic Porphyria Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Acute Hepatic Porphyria Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Acute Hepatic Porphyria Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Alnylam Pharmaceuticals Details, Company Type, Acute Hepatic Porphyria Drug Area Served and Its Competitors
Table 52. Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Product Offered
Table 53. Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Alnylam Pharmaceuticals Main Business
Table 55. Alnylam Pharmaceuticals Latest Developments
Table 56. Recordati Rare Diseases Details, Company Type, Acute Hepatic Porphyria Drug Area Served and Its Competitors
Table 57. Recordati Rare Diseases Acute Hepatic Porphyria Drug Product Offered
Table 58. Recordati Rare Diseases Main Business
Table 59. Recordati Rare Diseases Acute Hepatic Porphyria Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Recordati Rare Diseases Latest Developments
LIST OF FIGURES
Figure 1. Acute Hepatic Porphyria Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Acute Hepatic Porphyria Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Acute Hepatic Porphyria Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Acute Hepatic Porphyria Drug Sales Market Share by Country/Region (2022)
Figure 8. Acute Hepatic Porphyria Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Acute Hepatic Porphyria Drug Market Size Market Share by Type in 2022
Figure 10. Acute Hepatic Porphyria Drug in Hospital Pharmacy
Figure 11. Global Acute Hepatic Porphyria Drug Market: Hospital Pharmacy (2018-2023) & ($ Millions)
Figure 12. Acute Hepatic Porphyria Drug in Retail Pharmacy
Figure 13. Global Acute Hepatic Porphyria Drug Market: Retail Pharmacy (2018-2023) & ($ Millions)
Figure 14. Acute Hepatic Porphyria Drug in Online Pharmacy
Figure 15. Global Acute Hepatic Porphyria Drug Market: Online Pharmacy (2018-2023) & ($ Millions)
Figure 16. Acute Hepatic Porphyria Drug in Others
Figure 17. Global Acute Hepatic Porphyria Drug Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Acute Hepatic Porphyria Drug Market Size Market Share by Application in 2022
Figure 19. Global Acute Hepatic Porphyria Drug Revenue Market Share by Player in 2022
Figure 20. Global Acute Hepatic Porphyria Drug Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Acute Hepatic Porphyria Drug Market Size 2018-2023 ($ Millions)
Figure 22. APAC Acute Hepatic Porphyria Drug Market Size 2018-2023 ($ Millions)
Figure 23. Europe Acute Hepatic Porphyria Drug Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Acute Hepatic Porphyria Drug Market Size 2018-2023 ($ Millions)
Figure 25. Americas Acute Hepatic Porphyria Drug Value Market Share by Country in 2022
Figure 26. United States Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Acute Hepatic Porphyria Drug Market Size Market Share by Region in 2022
Figure 31. APAC Acute Hepatic Porphyria Drug Market Size Market Share by Type in 2022
Figure 32. APAC Acute Hepatic Porphyria Drug Market Size Market Share by Application in 2022
Figure 33. China Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Acute Hepatic Porphyria Drug Market Size Market Share by Country in 2022
Figure 40. Europe Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
Figure 41. Europe Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
Figure 42. Germany Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 56. APAC Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 57. Europe Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 59. United States Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 60. Canada Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 63. China Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 64. Japan Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 65. Korea Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 67. India Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 68. Australia Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 69. Germany Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 70. France Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 71. UK Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 72. Italy Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 73. Russia Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 74. Spain Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 77. Israel Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 80. Global Acute Hepatic Porphyria Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Acute Hepatic Porphyria Drug Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Acute Hepatic Porphyria Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Acute Hepatic Porphyria Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Acute Hepatic Porphyria Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Acute Hepatic Porphyria Drug Sales Market Share by Country/Region (2022)
Figure 8. Acute Hepatic Porphyria Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Acute Hepatic Porphyria Drug Market Size Market Share by Type in 2022
Figure 10. Acute Hepatic Porphyria Drug in Hospital Pharmacy
Figure 11. Global Acute Hepatic Porphyria Drug Market: Hospital Pharmacy (2018-2023) & ($ Millions)
Figure 12. Acute Hepatic Porphyria Drug in Retail Pharmacy
Figure 13. Global Acute Hepatic Porphyria Drug Market: Retail Pharmacy (2018-2023) & ($ Millions)
Figure 14. Acute Hepatic Porphyria Drug in Online Pharmacy
Figure 15. Global Acute Hepatic Porphyria Drug Market: Online Pharmacy (2018-2023) & ($ Millions)
Figure 16. Acute Hepatic Porphyria Drug in Others
Figure 17. Global Acute Hepatic Porphyria Drug Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Acute Hepatic Porphyria Drug Market Size Market Share by Application in 2022
Figure 19. Global Acute Hepatic Porphyria Drug Revenue Market Share by Player in 2022
Figure 20. Global Acute Hepatic Porphyria Drug Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Acute Hepatic Porphyria Drug Market Size 2018-2023 ($ Millions)
Figure 22. APAC Acute Hepatic Porphyria Drug Market Size 2018-2023 ($ Millions)
Figure 23. Europe Acute Hepatic Porphyria Drug Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Acute Hepatic Porphyria Drug Market Size 2018-2023 ($ Millions)
Figure 25. Americas Acute Hepatic Porphyria Drug Value Market Share by Country in 2022
Figure 26. United States Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Acute Hepatic Porphyria Drug Market Size Market Share by Region in 2022
Figure 31. APAC Acute Hepatic Porphyria Drug Market Size Market Share by Type in 2022
Figure 32. APAC Acute Hepatic Porphyria Drug Market Size Market Share by Application in 2022
Figure 33. China Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Acute Hepatic Porphyria Drug Market Size Market Share by Country in 2022
Figure 40. Europe Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
Figure 41. Europe Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
Figure 42. Germany Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Acute Hepatic Porphyria Drug Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 56. APAC Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 57. Europe Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 59. United States Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 60. Canada Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 63. China Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 64. Japan Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 65. Korea Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 67. India Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 68. Australia Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 69. Germany Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 70. France Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 71. UK Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 72. Italy Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 73. Russia Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 74. Spain Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 77. Israel Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Acute Hepatic Porphyria Drug Market Size 2024-2029 ($ Millions)
Figure 80. Global Acute Hepatic Porphyria Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Acute Hepatic Porphyria Drug Market Size Market Share Forecast by Application (2024-2029)
